Market News
Stay updated with the latest market trends, earnings, and economic indicators.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Groww, Lenskart, 9 other stocks among Motilal’s non-Nifty ideas. Check full list
Motilal Oswal has revealed its top non-Nifty stock picks. The brokerage anticipates robust earnings growth for these companies. Key names include ICICI Prudential AMC, TVS Motor, and Dixon Technologies. Delhivery shows the highest projected earnings expansion. Investors can explore these opportunities for potential gains.

The Great Consumption Reset: How a billion Indians changed what they buy
India's consumption landscape is evolving, with consumers favouring experiences, digital services, and premium products over basic goods. Kotak Mutual Fund's report shows a surge in foreign travel spending and premium smartphone sales, indicating a shift towards higher-value purchases.

Standard Chartered likely to exit ICICI Pru Life bancassurance tie-up; may join Bharti Life Insurance
Sources said the bank currently contributes around 5% to ICICI Prudential Life’s annualised premium equivalent (APE) and about 6% to its retail APE.

Life insurance new business premium rises 41% in April, SBI Life leads growth
Private life insurers report strong April start to FY27, led by SBI Life, ICICI Prudential, HDFC Life and LIC, with robust NBP and APE growth across segments.

Life insurers see double-digit premium growth in March; retail business performance varies
Life insurers report strong March premium growth, with Axis Max, ICICI Prudential and LIC showing gains but mixed trends in retail APE performance.
Mutual fund bulls vs FII bears: The Rs 38,000 crore battle for 5 popular bank stocks
Domestic mutual funds bought banking stocks worth Rs 38,000 crore in March, countering heavy FII selling of Rs 60,655 crore during the Iran war selloff. Major accumulation was seen in HDFC Bank, ICICI Bank, SBI, Kotak Mahindra Bank, and Axis Bank. HDFC Bank emerged as the top pick across leading mutual fund houses, according to Prime Database estimates.
HDFC Bank, BSE and Tata Motors among top stocks mutual funds bought and sold during March crash
Indian mutual funds aggressively bought equities last month amidst a market correction. They invested heavily in HDFC Bank and BSE, acting as a stabilising force against foreign investor selling. Funds also booked profits in Tata Motors. Banking stocks remain a dominant sector for mutual funds, with HDFC Bank, ICICI Bank, and SBI featuring prominently.
ICICI Prudential Life shares zoom 7% after Q4 profit surges 58%. Should you buy, sell or hold?
ICICI Prudential Life shares jumped 7% after the insurer reported a 58% YoY rise in Q4FY26 net profit to Rs 609 crore and announced a final dividend. For FY26, profit grew 35% to Rs 1,600 crore, aided by a stake sale. Net premium income rose 17%, driven by strong growth in one-time and renewal premiums.
Correction in NBFCs, IT and realty offers entry as earnings stay steady: Anupam Tiwari
Anupam Tiwari, Head of Equity at Groww Mutual Fund, expects a strong current quarter with limited impact from oil shocks so far, but flags risks from the next quarter onward. He remains positive on premium consumption, NBFCs, manufacturing exports and capex, while adding IT and premium real estate after corrections. He believes market fears may be overstated, with much of the downside already priced in.